AMY B. HEIMBERGER, M.D.
Radiology at Holcombe Blvd, Houston, TX
License number
Texas L6422
Category
Radiology
Type
Surgical Oncology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about AMY B. HEIMBERGER at radaris.comName
Address
Phone
412 E 7Th St, Houston, TX 77007
412 7Th St, Houston, TX 77007
412 7Th St, Houston, TX 77007
2500 Guerrero Dr, Carrollton, TX 75006
Organization information
See more information about AMY B. HEIMBERGER at bizstanding.comUniversity TX MD Anderson Cancer Center - Amy B Heimberger MD
1515 Holcombe Blvd UNIT 207, Houston, TX 77030
Categories:
Physicians & Surgeons
Phone:
(713) 792-6161 (Phone)
Professional information
Dr. Amy B Heimberger, Houston TX - MD (Doctor of Medicine)
Specialties:
Neurosurgery
Address:
MD Anderson Cancer Center NSG
1515 Holcombe Blvd SUITE 339, Houston 77030
(713) 792-6600 (Phone)
1515 Holcombe Blvd SUITE 339, Houston 77030
(713) 792-6600 (Phone)
Conditions:
Brain Cancer
Certifications:
Neurosurgery, 2005
Awards:
Healthgrades Honor Roll, American Association of Neurological Surgeons Young Clinical Investigator Award, 2003, American Association of Neurological Surgeons Preuss Award, 2000
Languages:
English, Spanish
Hospitals:
MD Anderson Cancer Center NSG
1515 Holcombe Blvd SUITE 339, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
1515 Holcombe Blvd SUITE 339, Houston 77030
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Saint Joseph's Medical Center
127 South Broadway, Yonkers 10701
Education:
Medical School
Washington University St Louis
Graduated: 1995
Duke University Med Center
Graduated: 1996
Graduated: 2002
Graduated: 1999
University Of Missouri
Graduated: 1985
Washington University St Louis
Graduated: 1995
Duke University Med Center
Graduated: 1996
Graduated: 2002
Graduated: 1999
University Of Missouri
Graduated: 1985
Amy B Heimberger, Houston TX
Specialties:
Neurosurgeon
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Washington University, School of Medicine - Doctor of Medicine
Duke University Hospital - Fellowship - Neuro-Oncology
Duke University Hospital - Residency - Neurological Surgery
Duke University Hospital - Internship - Surgery
Duke University Hospital - Fellowship - Neuro-Oncology
Duke University Hospital - Residency - Neurological Surgery
Duke University Hospital - Internship - Surgery
Board certifications:
American Board of Neurological Surgery Certification in Neurological Surgery
Amy Beth Heimberger, Houston TX
Specialties:
Neurological Surgery, Surgical Oncology
Work:
University of Texas M.D. Anderson Cancer
1515 Holcombe Blvd, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030
Education:
Washington University at St. Louis (1995) *, Duke University Medical Center (2002) *Neurological Surgery, Duke University Medical Center (2005) *Neurological Surgery
Blood Test For The Detection Of Cancer
US Patent:
2012002, Jan 26, 2012
Filed:
Jan 12, 2010
Appl. No.:
13/144250
Inventors:
Amy B. Heimberger - Houston TX, US
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
Methods of detecting cancers are provided. In certain embodiments, a blood test may utilized to identify the presence of a cancer such as, e.g., a melanoma or glioma (e.g., an astrocytoma, a glioblastoma multiforme) in a human patient. In particular, increased p-STAT3 expression by peripheral blood mononuclear cells is selectively associated with the presence of certain cancers. In various embodiments, fluorescence activated cell sorting (FACS) may be used to measure p-STAT3 expression in the peripheral blood of a human patient.
Interferon Therapies In Combination With Blockade Of Stat3 Activation
US Patent:
2013012, May 23, 2013
Filed:
Dec 4, 2010
Appl. No.:
13/513549
Inventors:
Waldemar Priebe - Houston TX, US
Amy Heimberger - Houston TX, US
Izabela Fokt - Houston TX, US
Timothy Madden - Sugarland TX, US
Charles Conrad - Spring TX, US
Amy Heimberger - Houston TX, US
Izabela Fokt - Houston TX, US
Timothy Madden - Sugarland TX, US
Charles Conrad - Spring TX, US
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
A61K 38/21, A61K 31/165, A61K 31/706, A61K 31/4164, A61K 45/06, A61K 31/216, A61K 31/44, A61K 31/277
US Classification:
424 854
Abstract:
Methods of modulating the INF-induced STAT3 activation in a patient in need-thereof are provided for the treatment of disease. The methods comprise the step of administrating to a patient the combination of a therapeutically effective amount of interferon including INF-α and/or INF-β in combination with a STAT3 inhibitor.
Concurrent Chemotherapy And Immunotherapy
US Patent:
2009022, Sep 3, 2009
Filed:
Nov 2, 2006
Appl. No.:
12/092180
Inventors:
John H. Sampson - Durham NC, US
Darell D. Bigner - Mebane NC, US
Mitchell Duane - Durham NC, US
Amy Heimberger - Houston TX, US
Darell D. Bigner - Mebane NC, US
Mitchell Duane - Durham NC, US
Amy Heimberger - Houston TX, US
Assignee:
Duke University - Durham NC
Univeristy of Texas M.D. Anderson Cancer Center - Houston TX
Univeristy of Texas M.D. Anderson Cancer Center - Houston TX
International Classification:
A61K 39/00, A61K 38/10, A61K 38/17, A61P 35/00
US Classification:
4242771, 514 14, 514 6, 4241841
Abstract:
The concurrent administration of chemotherapy and immunotherapy has been considered a contraindication because of the concern that the induced lymphopenia would ablate therapeutic efficacy of immunotherapy. Temozolomide has been shown to be an effective chemotherapeutic for patients with malignant gliomas and to deprive patients with glioblastoma (GBM) patients of this agent in order to treat with immunotherapy is controversial. Despite conventional dogma, we demonstrate that both chemotherapy and immunotherapy can be delivered concurrently without negating the effects of immunotherapy, in fact, the temozolomide induced lymphopenia may actually be synergistic with a peptide vaccine.
Small Molecule Inhibitors For Immune Modulation
US Patent:
2010014, Jun 10, 2010
Filed:
Mar 28, 2008
Appl. No.:
12/593280
Inventors:
Amy B. Heimberger - Houston TX, US
Waldemar Priebe - Houston TX, US
Izabela Fokt - Houston TX, US
Slawomir Szymanski - Houston TX, US
Sakina Hussain - Houston TX, US
Ling Y. Kong - Houston TX, US
Waldemar Priebe - Houston TX, US
Izabela Fokt - Houston TX, US
Slawomir Szymanski - Houston TX, US
Sakina Hussain - Houston TX, US
Ling Y. Kong - Houston TX, US
International Classification:
A61K 31/44, A61P 37/04
US Classification:
514357
Abstract:
Methods of treating immunosuppression by administering a therapeutic amount of a tryphostin compound of the formula: